UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Obesity as a risk factor for antipsychotic noncompliance

Schizophrenia research, 2004, Vol.66 (1), p.51-57

2004

Volltextzugriff (PDF)

Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder

Current medical research and opinion, 2016-03, Vol.32 (3), p.587-599

2016

Volltextzugriff (PDF)

Effect of desvenlafaxine 50 mg and 100 mg on energy and lassitude in patients with major depressive disorder: A pooled analysis

Journal of psychopharmacology (Oxford), 2017-09, Vol.31 (9), p.1204-1214

2017

Volltextzugriff (PDF)

Effectiveness and Safety of Donepezil in Hispanic Patients with Alzheimer’s Disease: A 12-Week Open-Label Study

Journal of the National Medical Association, 2008-11, Vol.100 (11), p.1350-1358

2008

Volltextzugriff (PDF)

The Impact of Weight Gain on Quality of Life Among Persons With Schizophrenia

Psychiatric services (Washington, D.C.), 2003-04, Vol.54 (4), p.565-567

2003

Volltextzugriff (PDF)

The Economic Impact of Migraine: An Analysis of Direct and Indirect Costs

Headache, 2002-06, Vol.42 (6), p.501-509

2002

Volltextzugriff (PDF)

Bodyweight gain associated with atypical antipsychotics. Epidemiology and therapeutic implications

CNS drugs, 2001, Vol.15 (7), p.537-551

2001

Volltextzugriff (PDF)

Reliability of monitoring the Clinical Dementia Rating in multicenter Clinical trials

Alzheimer disease and associated disorders, 2004-10, Vol.18 (4), p.219-222

2004

Volltextzugriff (PDF)

Relationship between preventative physical health care and mental health in individuals with schizophrenia: a survey of caregivers

Mental health services research, 2005-12, Vol.7 (4), p.225-228

2005

Volltextzugriff (PDF)

A Comprehensive Support Program: Effect on Depression in Spouse-Caregivers of AD Patients

The Gerontologist, 1995-12, Vol.35 (6), p.792-802

1995

Volltextzugriff (PDF)

An Intervention That Delays Institutionalization of Alzheimer's Disease Patients: Treatment of Spouse-Caregivers

The Gerontologist, 1993-12, Vol.33 (6), p.730-740

1993

Volltextzugriff (PDF)

Intrusions in alzheimer's disease in immediate and delayed memory as a function of presentation modality

Experimental aging research, 1996-10, Vol.22 (4), p.343-361

1996

Volltextzugriff (PDF)

Behavioral effects of current Alzheimer’s disease treatments: A descriptive review

Alzheimer's & dementia, 2008, Vol.4 (1), p.49-60

2008

Volltextzugriff (PDF)

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease

International journal of geriatric psychiatry, 2011-02, Vol.26 (2), p.150-157

2011

Volltextzugriff (PDF)

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

Journal of clinical psychopharmacology, 2017-10, Vol.37 (5), p.555-561

2017

Volltextzugriff (PDF)

Treatment Adherence Associated With Conventional and Atypical Antipsychotics in a Large State Medicaid Program

Psychiatric services (Washington, D.C.), 2003-05, Vol.54 (5), p.719-723

2003

Volltextzugriff (PDF)

An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder

International clinical psychopharmacology, 2016-05, Vol.31 (3), p.134

2016

Volltextzugriff (PDF)

Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine

Dementia and geriatric cognitive disorders, 2012-01, Vol.33 (2-3), p.164

2012

Volltextzugriff (PDF)

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response

BMC geriatrics, 2013-06, Vol.13 (1), p.56-56, Article 56

2013

Volltextzugriff (PDF)

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease

BMC research notes, 2012-06, Vol.5 (1), p.283-283, Article 283

2012

Volltextzugriff (PDF)

Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease

American journal of Alzheimer's disease and other dementias, 2012-09, Vol.27 (6), p.421

2012

Volltextzugriff (PDF)

Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis

Journal of Alzheimer's disease, 2010-01, Vol.21 (3), p.843

2010

Volltextzugriff (PDF)

Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain

Progress in neuro-psychopharmacology & biological psychiatry, 2004-12, Vol.28 (8), p.1287-1297

2004

Volltextzugriff (PDF)

Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease

Trials, 2011-10, Vol.12 (1), p.233-233, Article 233

2011

Volltextzugriff (PDF)

Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities

American journal of Alzheimer's disease and other dementias, 2010-09, Vol.25 (6), p.483

2010

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Obesity as a risk factor for antipsychotic noncompliance

Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder

Effect of desvenlafaxine 50 mg and 100 mg on energy and lassitude in patients with major depressive disorder: A pooled analysis

Effectiveness and Safety of Donepezil in Hispanic Patients with Alzheimer’s Disease: A 12-Week Open-Label Study

The Impact of Weight Gain on Quality of Life Among Persons With Schizophrenia

The Economic Impact of Migraine: An Analysis of Direct and Indirect Costs

Bodyweight gain associated with atypical antipsychotics. Epidemiology and therapeutic implications

Reliability of monitoring the Clinical Dementia Rating in multicenter Clinical trials

Relationship between preventative physical health care and mental health in individuals with schizophrenia: a survey of caregivers

A Comprehensive Support Program: Effect on Depression in Spouse-Caregivers of AD Patients

An Intervention That Delays Institutionalization of Alzheimer's Disease Patients: Treatment of Spouse-Caregivers

Intrusions in alzheimer's disease in immediate and delayed memory as a function of presentation modality

Behavioral effects of current Alzheimer’s disease treatments: A descriptive review

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

Treatment Adherence Associated With Conventional and Atypical Antipsychotics in a Large State Medicaid Program

An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder

Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease

Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease

Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis

Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain

Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease

Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities

Aktive Filter

Suchergebnisse filtern